Table 5 Proportion of patients receiving thrombolysis and proportion of hospitals providing investigations after admission
Advanced-level referral hospitals | N | Standard-level referral hospitals | N | Mid-level referral hospitals | N | |
|---|---|---|---|---|---|---|
Recombinant tissue plasminogen activator drug | ||||||
Average | 8.1% | 7 | 10.6% | 18 | 8.8% | 8 |
Antiplatelet drugs | ||||||
Median (IQR) | 99 (19) | 8 | 94 (13) | 17 | 92 (14) | 10 |
Min-max | 64–100 | 71–100 | 10–100 | |||
Electrocardiogram monitor | ||||||
Median (IQR) | 100 (−) | 8 | 98 (48) | 18 | 100 (2) | 11 |
Min-max | 99–100 | 6–100 | 80–100 | |||
Computerized tomography brain | ||||||
Median (IQR) | 100 (−) | 8 | 100 (−) | 19 | 100 (−) | 11 |
Min-max | 99–100 | 6–100 | 80–10 | |||
Magnetic resonance imaging/angiography | ||||||
Median (IQR) | 20 (78) | 6 | 2 (2) | 3 | 1 (5) | 3 |
Min-max | 1–100 | 1–5 | 1–10 | |||
Carotid doppler ultrasound | ||||||
Median (IQR) | 30 (20) | 2 | 10 (30) | 3 | 5 (49) | 4 |
Min-max | 10–50 | 2–62 | 1–98 | |||